Get Diamond plan for FREE

    logo

    Biofrontera Inc. (BFRIW)

    Price:

    0.05 USD

    ( - -0.01 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    BFRIW
    Name
    Biofrontera Inc.
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    Price
    0.050
    Market Cap
    583.989k
    Enterprise value
    5.030M
    Currency
    USD
    Ceo
    Hermann Luebbert
    Full Time Employees
    92
    Website
    biofrontera-us.com
    Ipo Date
    2021-10-29
    City
    Woburn
    Address
    120 Presidential Way

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Amneal Pharmaceuticals, Inc.

    VALUE SCORE:

    5

    Symbol
    AMRX
    Market Cap
    4.609B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    2nd position

    Neurocrine Biosciences, Inc.

    VALUE SCORE:

    9

    Symbol
    NBIX
    Market Cap
    13.144B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    The best

    Amphastar Pharmaceuticals, Inc.

    VALUE SCORE:

    10

    Symbol
    AMPH
    Market Cap
    1.271B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.561
    P/S
    0.287
    P/B
    -3.823
    Debt/Equity
    -1.900
    EV/FCF
    -1.012
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.327
    Earnings yield
    -1.781
    Debt/assets
    0.318
    FUNDAMENTALS
    Net debt/ebidta
    -0.091
    Interest coverage
    -43.930
    Research And Developement To Revenue
    0.100
    Intangile to total assets
    0.001
    Capex to operating cash flow
    -0.000
    Capex to revenue
    0.000
    Capex to depreciation
    0.005
    Return on tangible assets
    -1.142
    Debt to market cap
    0.460
    Piotroski Score
    3.000
    FUNDAMENTALS
    PEG
    -0.010
    P/CF
    -0.781
    P/FCF
    -0.844
    RoA %
    -113.993
    RoIC %
    -555.885
    Gross Profit Margin %
    65.965
    Quick Ratio
    0.803
    Current Ratio
    1.148
    Net Profit Margin %
    -47.281
    Net-Net
    -0.944
    FUNDAMENTALS PER SHARE
    FCF per share
    -1.114
    Revenue per share
    3.449
    Net income per share
    -1.631
    Operating cash flow per share
    -1.114
    Free cash flow per share
    -1.114
    Cash per share
    0.317
    Book value per share
    -0.239
    Tangible book value per share
    -0.242
    Shareholders equity per share
    -0.239
    Interest debt per share
    0.492
    TECHNICAL
    52 weeks high
    0.097
    52 weeks low
    0.050
    Current trading session High
    0.097
    Current trading session Low
    0.050
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.269
    logo
    Country
    IL
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.521
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -5.383

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.107
    logo
    Country
    IL
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.453
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.695
    logo
    Country
    CA
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.908
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.444
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.594
    DESCRIPTION

    Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

    NEWS